ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 111 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $162 | +15.7% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $140 | -0.7% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $141 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 200 | +809.1% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 22 | -99.3% | 0.00% | – |
| Q3 2018 | $73,000 | +2.8% | 3,200 | 0.0% | 0.00% | – |
| Q2 2018 | $71,000 | -2.7% | 3,200 | 0.0% | 0.00% | – |
| Q1 2018 | $73,000 | -13.1% | 3,200 | 0.0% | 0.00% | – |
| Q4 2017 | $84,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q3 2017 | $72,000 | -18.2% | 3,200 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | +14.3% | 3,200 | 0.0% | 0.00% | – |
| Q1 2017 | $77,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q4 2016 | $66,000 | +247.4% | 3,200 | +357.1% | 0.00% | – |
| Q3 2016 | $19,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
| Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
| Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
| Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
| Miura Global Management | 600,000 | $15,486,000 | 0.94% |
| DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
| Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
| Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
| Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |